211 related articles for article (PubMed ID: 29438359)
21. 17β-Estradiol inhibits ER stress-induced apoptosis through promotion of TFII-I-dependent Grp78 induction in osteoblasts.
Guo YS; Sun Z; Ma J; Cui W; Gao B; Zhang HY; Han YH; Hu HM; Wang L; Fan J; Yang L; Tang J; Luo ZJ
Lab Invest; 2014 Aug; 94(8):906-16. PubMed ID: 24933421
[TBL] [Abstract][Full Text] [Related]
22. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
23. Prunetin signals via G-protein-coupled receptor, GPR30(GPER1): Stimulation of adenylyl cyclase and cAMP-mediated activation of MAPK signaling induces Runx2 expression in osteoblasts to promote bone regeneration.
Khan K; Pal S; Yadav M; Maurya R; Trivedi AK; Sanyal S; Chattopadhyay N
J Nutr Biochem; 2015 Dec; 26(12):1491-501. PubMed ID: 26345541
[TBL] [Abstract][Full Text] [Related]
24. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
[TBL] [Abstract][Full Text] [Related]
25. Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice.
Balhuizen A; Kumar R; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2010 May; 320(1-2):16-24. PubMed ID: 20122988
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling.
Yu W; Zhu C; Xu W; Jiang L; Jiang S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 28009825
[TBL] [Abstract][Full Text] [Related]
27. Intracellular Distribution and Involvement of GPR30 in the Actions of E2 on C2C12 Cells.
Ronda AC; Boland RL
J Cell Biochem; 2016 Mar; 117(3):793-805. PubMed ID: 26359786
[TBL] [Abstract][Full Text] [Related]
28. Ligand-Independent G Protein-Coupled Estrogen Receptor/G Protein-Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17
Tutzauer J; Gonzalez de Valdivia E; Swärd K; Alexandrakis Eilard I; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
Mol Pharmacol; 2021 Sep; 100(3):271-282. PubMed ID: 34330822
[TBL] [Abstract][Full Text] [Related]
29. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
30. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation.
Song L; Zhao J; Zhang X; Li H; Zhou Y
Eur J Pharmacol; 2013 Aug; 714(1-3):15-22. PubMed ID: 23764463
[TBL] [Abstract][Full Text] [Related]
31. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane.
Filardo E; Quinn J; Pang Y; Graeber C; Shaw S; Dong J; Thomas P
Endocrinology; 2007 Jul; 148(7):3236-45. PubMed ID: 17379646
[TBL] [Abstract][Full Text] [Related]
32. SP600125 reduces lipopolysaccharide-induced apoptosis and restores the early-stage differentiation of osteoblasts inhibited by LPS through the MAPK pathway in MC3T3-E1 cells.
Guo C; Wang SL; Xu ST; Wang JG; Song GH
Int J Mol Med; 2015 May; 35(5):1427-34. PubMed ID: 25760015
[TBL] [Abstract][Full Text] [Related]
33. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30.
Carnesecchi J; Malbouyres M; de Mets R; Balland M; Beauchef G; Vié K; Chamot C; Lionnet C; Ruggiero F; Vanacker JM
PLoS One; 2015; 10(3):e0120672. PubMed ID: 25781607
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis.
Haas E; Meyer MR; Schurr U; Bhattacharya I; Minotti R; Nguyen HH; Heigl A; Lachat M; Genoni M; Barton M
Hypertension; 2007 Jun; 49(6):1358-63. PubMed ID: 17452498
[TBL] [Abstract][Full Text] [Related]
35. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18).
Evans NJ; Bayliss AL; Reale V; Evans PD
PLoS One; 2016; 11(3):e0152138. PubMed ID: 26998610
[TBL] [Abstract][Full Text] [Related]
37. Enrichment of miR-126 enhances the effects of endothelial progenitor cell-derived microvesicles on modulating MC3T3-E1 cell function via Erk1/2-Bcl-2 signalling pathway.
Chen G; Li P; Liu Z; Zeng R; Ma X; Chen Y; Xu H; Li Z; Lin H
Prion; 2019 Jan; 13(1):106-115. PubMed ID: 31050590
[TBL] [Abstract][Full Text] [Related]
38. 17β-estradiol rapidly activates calcium release from intracellular stores via the GPR30 pathway and MAPK phosphorylation in osteocyte-like MLO-Y4 cells.
Ren J; Wu JH
Calcif Tissue Int; 2012 May; 90(5):411-9. PubMed ID: 22392527
[TBL] [Abstract][Full Text] [Related]
39. [Estradiol significantly increases the expression of antioxidant enzymes in osteoporotic rats and osteoblasts in vitro].
Zhou XJ; Xia Y; Zhao YY; Gu WQ; Xiao X; Bai XC; Liu J; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):402-408. PubMed ID: 29735439
[TBL] [Abstract][Full Text] [Related]
40. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
Wróbel AM; Gregoraszczuk EŁ
Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
